Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 13Leukemia 5Recurrence 4Myelodysplastic Syndromes 2Solid Tumors 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid 1Leukemia, Erythroblastic, Acute 1Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies 1Aortic aneurysm, familial thoracic 4 1

Interventions

Cytarabine 56Etoposide 24Daunorubicin 22Filgrastim 18Busulfan 16fludarabine phosphate 14Mitoxantrone 14Idarubicin 14Cyclophosphamide 14Peripheral Blood Stem Cell Transplantation 12tipifarnib 11Gemtuzumab 11Flow Cytometry 9Cyclosporine 9Antilymphocyte Serum 9sargramostim 8Methotrexate 8Clofarabine 8Gene Expression Profiling 7Topotecan 6Radiotherapy 6Azacitidine 6valspodar 5alvocidib 5aldesleukin 5Melphalan 5Whole-Body Irradiation 4Observation 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Erythroblastic, Acute × quizartinib × Clear all
NCT00462761 2020-05-11

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Daiichi Sankyo

Phase 1 Completed
76 enrolled 12 charts
MyeloidOther hematologic neoplasm

Aortic aneurysm, familial thoracic 4, Leukemia, Erythroblastic, Acute, Leukemia, Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡